Occurrence of bla OXA-116 Carbapenemase in Escherichia coli ST2519 of Clinical Origin: A Report from Northeast India
Microbial Drug Resistance · 2024
DOI: 10.1089/mdr.2024.0022 ↗Kurz gefasst
Fachartikel in der Zeitschrift Microbial Drug Resistance, 2024. Verfasst von Bhaskar Jyoti Das und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Microbiology, Assam University, Silchar, India. Hauptthemen laut MEDLINE: beta-Lactamases, Anti-Bacterial Agents, Escherichia coli, Microbial Sensitivity Tests. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 36 Literaturangaben.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Microbiology, Assam University, Silchar, India.
- Department of Microbiology, Silchar Medical College and Hospital, Silchar, India.
Zitieren
APA
Das, B. J., Singha, K. M., Wangkheimayum, J., Chanda, D. D., & Bhattacharjee, A. (2024). Occurrence of bla OXA-116 Carbapenemase in Escherichia coli ST2519 of Clinical Origin: A Report from Northeast India. Microbial Drug Resistance. https://doi.org/10.1089/mdr.2024.0022
Vancouver
Das BJ, Singha KM, Wangkheimayum J, Chanda DD, Bhattacharjee A. Occurrence of bla OXA-116 Carbapenemase in Escherichia coli ST2519 of Clinical Origin: A Report from Northeast India. Microbial Drug Resistance. 2024. doi:10.1089/mdr.2024.0022
BibTeX
@article{Das2024,
author = {Das, Bhaskar Jyoti and Singha, K Melson and Wangkheimayum, Jayalaxmi and Chanda, Debadatta Dhar and Bhattacharjee, Amitabha},
title = {Occurrence of bla OXA-116 Carbapenemase in Escherichia coli ST2519 of Clinical Origin: A Report from Northeast India},
journal = {Microbial Drug Resistance},
year = {2024},
doi = {10.1089/mdr.2024.0022}
}
EUVIMED